Inflammatory mediators and redox-sensitive signaling proteins

Inflammatory mediators and redox-sensitive signaling proteins represent a broad functional category of molecules that coordinate the body's response to injury, infection, and oxidative stress. This group includes key transcription factors such as Nuclear Factor-kappa B (NF-κB), which drives the expression of pro-inflammatory genes, and Nuclear factor erythroid 2-related factor 2 (Nrf2), which regulates the antioxidant defense system (PMID: 21130707, 24430312). These proteins are characterized by their ability to sense changes in the cellular reduction-oxidation (redox) state, often through the modification of sensitive cysteine residues that alter protein conformation and activity (PMID: 28246318). In chronic diseases like rheumatoid arthritis, atherosclerosis, and Alzheimer's disease, the persistent activation of inflammatory mediators and the failure of redox-sensitive protective mechanisms lead to tissue damage and disease progression. Pharmacological intervention typically involves either the inhibition of pro-inflammatory cytokines and kinases or the activation of cytoprotective redox pathways to restore homeostatic balance. However, because these signaling networks are integral to normal physiological processes like wound healing and pathogen defense, therapeutic targeting must be carefully calibrated to avoid significant toxicity or immune compromise.

Other names

Redox-sensitive inflammatory pathwaysPro-inflammatory signaling moleculesOxidative stress-responsive proteinsRedox-regulated signaling network

Modulation of cellular redox status and inhibition of pro-inflammatory gene expression through the targeting of transcription factors (e.g., NF-κB, Nrf2), kinases (e.g., MAPKs), and soluble mediators (e.g., TNF-α, IL-6).